Zevra Therapeutics, Inc. (ZVRA)
NASDAQ: ZVRA · Real-Time Price · USD
12.04
+0.39 (3.35%)
Aug 25, 2026, 4:00 PM EDT - Market closed
Zevra Therapeutics Stock Forecast
Stock Price Forecast
According to 9 analysts polled by S&P Global, Zevra Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $25. The average 1-year stock price forecast is 107.64% higher than the current stock price, while the lowest is $20 (+66.11%) and the highest is $35 (+190.70%).
Price Target: $25 (+107.64%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Zevra Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 7 | 7 | 7 | 7 | 7 | 7 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 9 | 9 | 9 | 9 | 9 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $26 | Buy | Reiterates | $26 | +115.95% | Aug 20, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $20 | Buy | Reiterates | $20 | +66.11% | Aug 12, 2026 |
| Maxim Group | Maxim Group | Buy Maintains $35 | Buy | Maintains | $35 | +190.70% | Aug 7, 2026 |
| Guggenheim | Guggenheim | Buy Maintains $24 → $23 | Buy | Maintains | $24 → $23 | +91.03% | Aug 7, 2026 |
| Roth MKM | Roth MKM | Buy Maintains $21 | Buy | Maintains | $21 | +74.42% | Aug 6, 2026 |
Financial Forecast
Revenue This Year
152.22M
from 106.47M
Increased by 42.97%
Revenue Next Year
176.98M
from 152.22M
Increased by 16.27%
EPS This Year
1.14
from 1.35
Decreased by -15.56%
EPS Next Year
1.05
from 1.14
Decreased by -7.89%
EPS and Forward PE are based on non-GAAP adjusted numbers.